Trends in Mortality after Intensive Care of Patients with Aneurysmal Subarachnoid Hemorrhage in Finland in 2003-2019: A Finnish Intensive Care Consortium study.


Journal

Neurocritical care
ISSN: 1556-0961
Titre abrégé: Neurocrit Care
Pays: United States
ID NLM: 101156086

Informations de publication

Date de publication:
10 2022
Historique:
received: 10 10 2021
accepted: 08 12 2021
pubmed: 31 12 2021
medline: 1 10 2022
entrez: 30 12 2021
Statut: ppublish

Résumé

Previous studies suggest that case mortality of aneurysmal subarachnoid hemorrhage (aSAH) has decreased during the last decades, but most studies have been unable to assess case severities among individual patients. We aimed to assess changes in severity-adjusted aSAH mortality in patients admitted to intensive care units (ICUs). We conducted a retrospective, register-based study by using the prospectively collected Finnish Intensive Care Consortium database. Four out of five ICUs providing neurosurgical and neurointensive care in Finland participated in the Finnish Intensive Care Consortium. We extracted data on adult patients admitted to Finnish ICUs with aSAH between 2003 and 2019. The primary outcome was 12-month mortality during three periods: 2003-2008, 2009-2014, and 2015-2019. Using a multivariable logistic regression model-with variables including age, sex, World Federation of Neurological Surgeons grade, preadmission dependency, significant comorbidities, and modified Simplified Acute Physiology Score II-we analyzed whether admission period was independently associated with mortality. A total of 1,847 patients were included in the study. For the periods 2003-2008 and 2015-2019, the mean number of patients with aSAH admitted per year increased from 81 to 123. At the same time, the patients' median age increased from 55 to 58 years (p = 0.001), and the proportion of patients with World Federation of Neurological Surgeons grades I-III increased from 42 to 58% (p < 0.001). The unadjusted 12-month mortality declined from 30% in 2003-2008 to 23% in 2015-2019 (p = 0.001), but there was no statistically significant change in severity-adjusted mortality. Between 2003 and 2019, patients with aSAH admitted to ICUs became older and the proportion of less severe cases increased. Unadjusted mortality decreased but age and case severity adjusted-mortality remained unchanged.

Sections du résumé

BACKGROUND
Previous studies suggest that case mortality of aneurysmal subarachnoid hemorrhage (aSAH) has decreased during the last decades, but most studies have been unable to assess case severities among individual patients. We aimed to assess changes in severity-adjusted aSAH mortality in patients admitted to intensive care units (ICUs).
METHODS
We conducted a retrospective, register-based study by using the prospectively collected Finnish Intensive Care Consortium database. Four out of five ICUs providing neurosurgical and neurointensive care in Finland participated in the Finnish Intensive Care Consortium. We extracted data on adult patients admitted to Finnish ICUs with aSAH between 2003 and 2019. The primary outcome was 12-month mortality during three periods: 2003-2008, 2009-2014, and 2015-2019. Using a multivariable logistic regression model-with variables including age, sex, World Federation of Neurological Surgeons grade, preadmission dependency, significant comorbidities, and modified Simplified Acute Physiology Score II-we analyzed whether admission period was independently associated with mortality.
RESULTS
A total of 1,847 patients were included in the study. For the periods 2003-2008 and 2015-2019, the mean number of patients with aSAH admitted per year increased from 81 to 123. At the same time, the patients' median age increased from 55 to 58 years (p = 0.001), and the proportion of patients with World Federation of Neurological Surgeons grades I-III increased from 42 to 58% (p < 0.001). The unadjusted 12-month mortality declined from 30% in 2003-2008 to 23% in 2015-2019 (p = 0.001), but there was no statistically significant change in severity-adjusted mortality.
CONCLUSIONS
Between 2003 and 2019, patients with aSAH admitted to ICUs became older and the proportion of less severe cases increased. Unadjusted mortality decreased but age and case severity adjusted-mortality remained unchanged.

Identifiants

pubmed: 34966958
doi: 10.1007/s12028-021-01420-z
pii: 10.1007/s12028-021-01420-z
pmc: PMC9519655
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

447-454

Informations de copyright

© 2021. The Author(s).

Références

Nieuwkamp DJ, Setz LE, Algra A, Linn FH, de Rooij NK, Rinkel GJ. Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol. 2009;8(7):635–42.
doi: 10.1016/S1474-4422(09)70126-7
Boogaarts HD, van Amerongen MJ, de Vries J, et al. Caseload as a factor for outcome in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis: a systematic review. J Neurosurg. 2014;120(3):605–11.
doi: 10.3171/2013.9.JNS13640
Connolly ES, Rabinstein AA, Carhuapoma JR, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American heart association/American stroke association [Internet]. Stroke. 2012;43(6):1711–37.
doi: 10.1161/STR.0b013e3182587839
Steiner T, Juvela S, Unterberg A, Jung C, Forsting M, Rinkel G. European stroke organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage [Internet]. Cerebrovasc Dis. 2013;35(2):93–112.
doi: 10.1159/000346087
Anetsberger A, Gempt J, Blobner M, et al. Impact of goal-directed therapy on delayed ischemia after aneurysmal subarachnoid hemorrhage. Stroke. 2020;51(8):2287–96.
doi: 10.1161/STROKEAHA.120.029279
Molyneux AJ, Kerr RS, Yu L-M, et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet. 2005;366(9488):809–17.
doi: 10.1016/S0140-6736(05)67214-5
Janssen H, Berlis A, Lutz J, Thon N, Brückmann H. State of practice: endovascular treatment of acute aneurysmal SAH in Germany. Am J Neuroradiol. 2017;38(8):1574–9.
doi: 10.3174/ajnr.A5260
Golnari P, Nazari P, Garcia RM, et al. Volumes, outcomes, and complications after surgical versus endovascular treatment of aneurysms in the United States (1993–2015): continued evolution versus steady-state after more than 2 decades of practice. J Neurosurg. 2021;134(3):848–61.
doi: 10.3171/2019.12.JNS192755
Nieuwkamp DJ, Vaartjes I, Algra A, Bots ML, Rinkel GJE. Age- and gender-specific time trend in risk of death of patients admitted with aneurysmal subarachnoid hemorrhage in the Netherlands. Int J Stroke. 2013;8(100A):90–4.
doi: 10.1111/ijs.12006
Rincon F, Rossenwasser RH, Dumont A. The epidemiology of admissions of nontraumatic subarachnoid hemorrhage in the United States. Neurosurgery. 2013;73(2):217–22.
doi: 10.1227/01.neu.0000430290.93304.33
Mukhtar TK, Molyneux AJ, Hall N, et al. The falling rates of Hospital Admission, case fatality, and population-based mortality for subarachnoid hemorrhage in England, 1999–2010. J Neurosurg. 2016;125(3):698–704.
doi: 10.3171/2015.5.JNS142115
Worthington JM, Goumas C, Jalaludin B, Gattellari M. Decreasing risk of fatal subarachnoid hemorrhage and other epidemiological trends in the era of coiling Implementation in Australia. Front Neurol. 2017;8:424.
doi: 10.3389/fneur.2017.00424
Mackey J, Khoury JC, Alwell K, et al. Stable incidence but declining case-fatality rates of subarachnoid hemorrhage in a population. Neurology. 2016;87(21):2192–7.
doi: 10.1212/WNL.0000000000003353
Udy AA, Vladic C, Saxby ER, et al. Subarachnoid hemorrhage patients admitted to intensive care in Australia and New Zealand: a multicenter cohort analysis of in-hospital mortality over 15 years. Crit Care Med. 2017;45(2):e135–45.
doi: 10.1097/CCM.0000000000002059
Reinikainen M, Mussalo P, Hovilehto S, et al. Association of automated data collection and data completeness with outcomes of intensive care. A new customised model for outcome prediction. Acta Anaesthesiol Scand. 2012;56(9):1114–22.
doi: 10.1111/j.1399-6576.2012.02669.x
Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270(24):2957–63.
doi: 10.1001/jama.1993.03510240069035
Drake C, Hunt W, Sano K, Kassell N, Teasdale G, Pertuiset B. Report of world federation of neurological surgeons committee on a universal subarachnoid hemorrhage grading scale. J Neurosurg. 1988;68(6):985–6.
Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–55.
doi: 10.1097/00000421-198212000-00014
Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818–29.
doi: 10.1097/00003246-198510000-00009
Cullen DJ, Civetta JM, Briggs BA, Ferrara LC. Therapeutic intervention scoring system: a method for quantitative comparison of patient care. Crit Care Med. 1974;2(2):57–60.
doi: 10.1097/00003246-197403000-00001
Miranda DR, De Rijk A, Schaufeli W. Simplified therapeutic intervention scoring system: the TISS-28 items—results from a multicenter study. Crit Care Med. 1996;24(1 SUPPL.):64–73.
doi: 10.1097/00003246-199601000-00012
Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. UroToday Int J. 2009;2(2):806–8.
Rautalin I, Lindbohm JV, Kaprio J, Korja M. Substantial within-country variation in the incidence of subarachnoid hemorrhage. Neurology. 2021;97(1):e52-60.
doi: 10.1212/WNL.0000000000012129
Bagshaw SM, Webb SAR, Delaney A, et al. Very old patients admitted to intensive care in Australia and New Zealand: a multi-centre cohort analysis. Crit Care. 2009;13(2):R45.
doi: 10.1186/cc7768
Heo J, Hong Y, Han SS, et al. Changes in the characteristics and long-term mortality rates of intensive care unit patients from 2003 to 2010: a nationwide population-based cohort study performed in the Republic of Korea [Internet]. Acute Crit Care. 2018;33(3):135–45.
doi: 10.4266/acc.2018.00164
Jolink WMT, Klijn CJM, Brouwers PJAM, Kappelle LJ, Vaartjes I. Time trends in incidence, case fatality, and mortality of intracerebral hemorrhage. Neurology. 2015;85(15):1318–24.
doi: 10.1212/WNL.0000000000002015
Béjot Y, Grelat M, Delpont B, et al. Temporal trends in early case-fatality rates in patients with intracerebral hemorrhage. Neurology. 2017;88(10):985–90.
doi: 10.1212/WNL.0000000000003681
Sipilä JOT, Ruuskanen JO, Rautava P, Kytö V. Case fatality of hospital-treated intracerebral hemorrhage in Finland—a nationwide population-based registry study. J Neurol Sci. 2021;425:117446.
doi: 10.1016/j.jns.2021.117446
Carlsson M, Wilsgaard T, Johnsen SH, et al. Temporal trends in incidence and case fatality of intracerebral hemorrhage: the tromsø study 1995–2012. Cerebrovasc Dis Extra. 2016;6(2):40–9.
doi: 10.1159/000447719
Prabhakaran S, Fonarow GC, Smith EE, et al. Hospital case volume is associated with mortality in patients hospitalized with subarachnoid hemorrhage. Neurosurgery. 2014;75(5):500–8.
doi: 10.1227/NEU.0000000000000475
Pandey AS, Gemmete JJ, Wilson TJ, et al. High subarachnoid hemorrhage patient volume associated with lower mortality and better outcomes. Neurosurgery. 2015;77(3):462–70.
doi: 10.1227/NEU.0000000000000850
Schatlo B, Fung C, Stienen MN, et al. Incidence and outcome of aneurysmal subarachnoid hemorrhage: the Swiss Study on Subarachnoid Hemorrhage (Swiss SOS). Stroke. 2020;52:344–7.
doi: 10.1161/STROKEAHA.120.029538
Lindbohm JV, Kaprio J, Jousilahti P, Salomaa V, Korja M. Risk factors of sudden death from subarachnoid hemorrhage. Stroke. 2017;48(9):2399–404.
doi: 10.1161/STROKEAHA.117.018118
Neifert SN, Chapman EK, Martini ML, et al. Aneurysmal subarachnoid hemorrhage: the last decade [Internet]. Transl Stroke Res. 2021;12(3):428–46.
doi: 10.1007/s12975-020-00867-0

Auteurs

Jyri J Virta (JJ)

Department of Neurosurgery, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. jyri.virta@hus.fi.
Division of Anesthesiology, Department of Anesthesiology, Intensive Care and Pain Medicine, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. jyri.virta@hus.fi.

Markus Skrifvars (M)

Department of Emergency Care and Services, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.

Matti Reinikainen (M)

Department of Anesthesiology and Intensive Care, Kuopio University Hospital, University of Eastern Finland, Kuopio, Finland.

Stepani Bendel (S)

Department of Anesthesiology and Intensive Care, Kuopio University Hospital, University of Eastern Finland, Kuopio, Finland.

Ruut Laitio (R)

Department of Perioperative Services, Intensive Care and Pain Management, Turku University Hospital, University of Turku, Turku, Finland.

Sanna Hoppu (S)

Department of Intensive Care and Emergency Medicine Services, Department of Emergency, Anesthesia and Pain Medicine, Tampere University Hospital, University of Tampere, Tampere, Finland.

Tero Ala-Kokko (T)

Research Group of Surgery, Anesthesiology and Intensive Care, Division of Intensive Care, Oulu University Hospital, University of Oulu, Medical Research Center, Oulu, Finland.

Jari Siironen (J)

Department of Neurosurgery, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.

Rahul Raj (R)

Department of Neurosurgery, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH